As of 23 March, there were 336,000 confirmed cases of COVID-19 in the world, with more than 250,000 cases outside China. Despite these numbers, much is still misunderstood or unknown about the virus which has brought regions of the globe to a standstill and placed huge pressure on the global economy.
Even what we do know – that elderly people are more at risk, that this is a new virus but resembles other known epidemics, that it is highly infectious – requires more explanation.
Here, Belgian virologist Guido Vanham, the former head of virology at the Institute for Tropical Medicine in Antwerp, Belgium, helps answer questions about COVID-19's origins, its behaviour and its future.
Have you read?
This interview, conducted by Maria Epifanova, was originally published by Novaya Gazeta. This English translation has been updated and authorized for sharing with the World Economic Forum.
I would like to start with a general question: there are a lot of discussions and speculations about COVID-19, but could you summarize the facts that we know about the virus for sure?
It is certainly a new virus for the human population. It resembles very much the SARS virus which emerged in 2003. That also was an epidemic but it was limited to a few thousand people in several places in the world with the death rate of about 10%. It also relates, but less closely, to another virus which emerged a few years later – the MERS virus. It was even more deadly, it killed one in three people who got infected.
But both of these epidemics disappeared following much less drastic measures than the ones implemented today. The present virus, COVID-19, is clearly more infectious and is mainly transmitted via aerosols (from people who cough or sneeze etc), but you can also get it by contact with objects that infected people, who are not necessarily sick, have touched.
It has spread all over the world and is present in almost all countries where they are able to test for it. This is also different from the previous epidemics because it took a long time to test for those – now we already have tests. It belongs to a family of viruses that is named “corona” – which comes from the Latin for “crown” and refers to the structure of these viruses as under the electron microscope it looks like a crown.
This family of coronaviruses has been with humans and animals for a long time and causes mild infections like the common cold, but this new virus is much more aggressive than all other members of the family. The symptoms are very similar to some extent to heavy flu but it is much more deadly; at least 5% of those who get infected and show symptoms might die. There may also be many infected people who do not get sick and that we do not test.
It is a completely different virus from the Influenza viruses which belong to a very different group, meaning that flu vaccine or flu medication will not help. For now, we have no medication or vaccine for the virus. The genetic structure of this virus and a flu virus are as different as we are from dinosaurs.— Guido Vanham
Many people still compare this virus to SARS and believe the measures taken by governments are excessive. Why should we not compare it with SARS? Is it more dangerous?
We have to compare it with SARS because it looks very much like SARS. The relationship between this virus and SARS is very close: they have many identical parts in their genome, so it is really to some extent a SARS-2 virus. It is, however, much more infectious. The estimation now is that any person infected with this virus may infect three other people, which leads to an exponential growth of the epidemic – that was not the case with SARS. It is also clear that people without symptoms can spread the virus.
Can we explain why it is so infectious?
No. There is some understanding of why SARS, MERS and COVID-19 are related and why they produce heavy symptoms, but why this particular virus is much more infectious than other related viruses is something we still do not know. That is a matter of research. Remarkably, the previous SARS Cov1 and the present SARS CoV2 use the same “receptor” for entry in cells and the suggestion is that the “envelope proteins” of the present SARS CoV2 are just more efficient in using the “entry door” into the lung cells and elsewhere in the body.
Why is it aggressive for elderly people but almost harmless to even newborn kids?
I cannot give you a final answer to that but this is not so uncommon. Other viruses behave less aggressively in children than in adults or elderly people. Children’s immune systems react in a less vigorous (in this case also more appropriate) way and they don’t get that sick; the immune system of adults sometimes overreacts to those viruses and that makes them sick.
People who are weaker because of other diseases are less resistant in general. It is clear, the older you get the more risk there is, but there are also people in their 30s and 40s in our hospitals who are very ill but most will survive, while many more older people might die.
You’ve mentioned that people without symptoms can also infect other people, but isn’t this common for all viruses?
Indeed, most other viruses have this characteristic but the proportion of people who can transmit the virus without symptoms is different for different viruses. For COVID-19, we have no exact numbers yet.
What can we say about people who get the virus and recover? Do they get immunity? Reinfections have been recorded; on the other hand, the British scenario assumes that herd immunity will develop.
That is very much the question. There is no convincing evidence at that moment that people who have gone through the infection and recovered will become immune and won’t be reinfected. There is a suggestion that they can become susceptible again after a short period of time.
The famous “herd immunity” concept may occur in the end but it always requires a large proportion of the population to first get infected, overcome the infection and then maintain sufficient levels of antibodies to not get infected again. In that scenario, the virus can no longer spread but has to “wait” until there are enough “new” individuals without immunity (i.e. young children) – a scenario like the classical “childhood infections” such as measles, mumps, rubella, before the vaccination. The other scenario is that the virus mutates and can overcome the herd immunity, much like Influenza does.
What is the World Economic Forum doing about the coronavirus outbreak?
Responding to the COVID-19 pandemic requires global cooperation among governments, international organizations and the business community, which is at the centre of the World Economic Forum’s mission as the International Organization for Public-Private Cooperation.
Since its launch on 11 March, the Forum’s COVID Action Platform has brought together 1,667 stakeholders from 1,106 businesses and organizations to mitigate the risk and impact of the unprecedented global health emergency that is COVID-19.
The platform is created with the support of the World Health Organization and is open to all businesses and industry groups, as well as other stakeholders, aiming to integrate and inform joint action.
As an organization, the Forum has a track record of supporting efforts to contain epidemics. In 2017, at our Annual Meeting, the Coalition for Epidemic Preparedness Innovations (CEPI) was launched – bringing together experts from government, business, health, academia and civil society to accelerate the development of vaccines. CEPI is currently supporting the race to develop a vaccine against this strand of the coronavirus.
So now the only way forward is to reduce social contact and then what? Wait for the treatment or wait for the vaccine?
Yes, but it’s doubtful that treatment will be available within weeks. The more likely scenario is that this epidemic will continue and will end at some point. Here we look at China because, according to the official numbers, there are no new “endogenous” infections; in China, the epidemic looks to be over.
We know that the Chinese have taken very strict measures and even prevented people from leaving their homes. That is not the case here [in Belgium]; we are not locked up, but social contacts are reduced to a minimum.
But you can’t stay at home forever.
No, we shouldn’t. Today, I went out. We keep a distance and we don’t gather more than three people – that is forbidden.
In Latvia, where I live now, different measures are being taken: schools are closed, public gatherings prohibited, restaurants are closing and so on. It is advised to minimize contact. The current measures are in place for a month. What I am trying to understand is what is supposed to happen within a month? If people reduce contact, the numbers are likely to go down, but then, when people start living their normal life again, won’t that cause another wave?
That is, of course, the risk if you lift the measures too early – you can get a second wave. It will be very difficult to decide when to lift the measures. But most European countries saw what happened in Italy and have taken measures now, at an earlier stage. Italy was clearly too late, but when you are at an earlier stage, the impact of such measures is bigger. That is our hope and we will know in a few weeks if that hope is justified.
I see your point, but can we hope, for example, that the virus will start to slow down owing to some natural factor (summer or whatever else), as happened with SARS?
That is a possibility. The other point is that for every virus, not every human is equally susceptible. There are always people in a population who are more or less susceptible to a certain virus.
In this epidemic, if it follows the natural course, only a certain proportion of the population will be infected. That proportion could be bigger than in the surrounding countries who took restrictive measures, but in the later-acting countries, after restrictions are lifted, a second wave may come. This has been seen in other bacteria or viruses but is something we will only know afterwards – we cannot predict it. This is just the law of evolution, but we don’t yet know the proportion of people not susceptible to this virus. This will depend on the genetic constitution of people and we are all different.
It also depends on the characteristics of the virus, because the virus will be changing and adapting – that is what happens with the flu and other viruses. A similar thing is likely to happen with this virus.
In that case we will still live with COVID-19 but a modified type of it?
Personally, I think that is very likely to happen.
In that case it is likely to get more or less severe?
It is difficult to foresee. I am an HIV specialist and we have been looking at HIV for 30 or 40 years now. It is difficult to say whether it is more or less severe than it was 30 years ago. The “problem” (from an evolutionary point of view) is that we have treatment for HIV, so, very fortunately, that natural evolution no longer happens.
The same thing might happen with coronavirus: the treatment or vaccine will become available and we will never see this natural evolution. Viruses, especially of those types, tend to be very inventive and they adapt. This virus is new for the human population but is 96% identical to a virus transmitted within bats. That is very close – with HIV you have a variation of 20%, so one type of HIV can be only 80% identical to another.
Is it good or bad news for us?
This virus existed and changed at some point – that 4% of difference is important, as it means the virus started to infect people. The same happened 100 years ago with the simian immunodeficiency virus, the HIV analogue for monkeys, which jumped from monkeys to humans. Now it is a human virus.
This COVID is now a human virus too and will spread into the human population. If we do not stop it with modern technologies, like a vaccine, it will stay with humans for hundreds of years.
The US has already announced testing of a vaccine. How long should it take?
There is a lot of technology available, different platforms to use, but in the end, you cannot predict [how long it will take]. Take the story of hepatitis: in the 1980s, the first vaccine was developed for hepatitis B; there is now a vaccine for hepatitis A, but hepatitis C has no vaccine. Furthermore, HIV has no vaccine – and we’ve been looking for 30 years.
The problem is, there are animal viruses related to coronaviruses (the feline enteric coronavirus, for example), where the vaccine proved to be dangerous: the vaccinated cats got an even more severe infection.
The danger is that people or companies and academics will rush into vaccine trials without taking precautions and accidents may happen. But again, we cannot predict – it could be as simple as the measles vaccine. I, along with you and everybody else on earth, do hope so.
If it appears to be as difficult as producing a vaccine for HIV, what is the most probable scenario?
Well, I am not that pessimistic; I know HIV very well and I know why it is so difficult. This COVID virus is closely related to the SARS virus – up to 95% – so maybe the possibility for the virus to change (it’s “genetic space”) is not that large. Testing in vitro suggests antibodies for SARS could neutralize this virus, so maybe it will be fine; maybe in half a year's time we will have a realistic perspective on a vaccine. But, as I just explained, there are risks that should be taken into account.
We will all live between hope and fear for a while. In the end, humankind will overcome this challenge too – but we will pay a price.